Sensus Healthcare, Inc. SRTS

Company Overview

Sensus Healthcare, Inc. is a U.S.-based medical device company focused on non-invasive and minimally invasive treatments for oncological and dermatological conditions. The company develops and commercializes superficial radiotherapy (SRT) systems that use low-dose X-ray technology for the treatment of non-melanoma skin cancers, keloids, and other skin-related conditions. Sensus Healthcare operates within the healthcare technology and radiation oncology sectors, with its primary revenue generated from the sale, lease, and servicing of radiation therapy systems and related consumables. The company’s customer base includes dermatologists, radiation oncologists, hospital systems, and specialty treatment clinics.

The company is best known for its SRT-100, SRT-100 Vision, and SRT-100+ platforms, which are designed to deliver targeted superficial radiation therapy with image-guided capabilities. Sensus Healthcare positions itself as a provider of alternatives to surgical skin cancer treatments, particularly for patients seeking non-surgical options. Founded in 2010 and headquartered in Boca Raton, Florida, the company expanded through continued development of image-guided radiotherapy technologies and selective international distribution relationships. Public filings, including SEC filings, indicate that the company has emphasized operational efficiency and recurring service-related revenue alongside device sales.